Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 23 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 11369566

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  2. US 11371062

    RNA-guided nucleic acid modifying enzymes and methods of use thereof

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  3. US 11369688

    Hybrid telodendrimers

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  4. US 11369644

    Microbial consortia

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  5. US 11366121

    Specific GNAI:GIV interaction screening assays, methods and compositions

    The Regents of the University of California · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  6. US 11358940

    K-Ras modulators

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  7. US 11358947

    Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  8. US 11357872

    Imaging neurotransmitters in vivo using functionalized carbon nanotubes

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  9. US 11357817

    Immunoproteasome inhibitor

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  10. US 11359024

    Anti-AVB8 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  11. US 11357830

    Nano-scale delivery device and uses thereof

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  12. US 11357736

    Detoxification using nanoparticles

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  13. US 11353463

    Redox-based reagents for methionine bioconjugation

    The Regents of the University of California · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  14. US 11351161

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  15. US 11344559

    PI3KGAMMA inhibitors

    The Regents of the University of California · Granted May 31, 2022 · Expires May 26, 2042

    granted

  16. US 11344555

    Nucleotide analogs

    The Regents of the University of California · Granted May 31, 2022 · Expires May 26, 2042

    granted

  17. US 11344526

    Implantable drug delivery devices for localized drug delivery

    The Regents of the University of California · Granted May 31, 2022 · Expires May 26, 2042

    granted

  18. US 11344491

    Compositions and methods of using the same for decontamination of skin

    The Regents of the University of California · Granted May 31, 2022 · Expires May 26, 2042

    granted

  19. US 11339193

    CDP protein secretion inhibitors

    The Regents of the University of California · Granted May 24, 2022 · Expires May 19, 2042

    granted

  20. US 11338119

    Implantable drug delivery devices for localized drug delivery

    The Regents of the University of California · Granted May 24, 2022 · Expires May 19, 2042

    granted

  21. US 11332727

    Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector

    The Regents of the University of California · Granted May 17, 2022 · Expires May 12, 2042

    granted

  22. US 11332482

    Au(III) complexes for [18F] Trifluoromethylation and methods for producing the same

    The Regents of the University of California · Granted May 17, 2022 · Expires May 12, 2042

    granted

  23. US 11332716

    Methods and compositions for producing pancreatic beta cells

    The Regents of the University of California · Granted May 17, 2022 · Expires May 12, 2042

    granted

  24. US 11331346

    Targeted replacement of endogenous T cell receptors

    The Regents of the University of California · Granted May 17, 2022 · Expires May 12, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.